Comparison of Different Magnesium Sulphate Regimens in Pregnant Women With Severe Preeclampsia at Ain Shams University Maternity Hospital (Observational)

What this Trial Is About

This research aims to understand the effects of different magnesium sulphate treatment plans for severe pre-eclampsia, a condition that raises blood pressure in some pregnant women and can lead to seizures. The study reviews patient records from the past five years at Ain Shams University Maternity Hospital to identify how magnesium sulphate was used to prevent seizures in these women. The study is retrospective, analyzing hospital records to describe the various magnesium sulphate regimens given to patients diagnosed with severe pre-eclampsia. Researchers will collect detailed information about the doses, routes, and duration of magnesium sulphate treatment, including any dosage changes and reasons, as well as side effects and signs of toxicity. They will also observe the occurrence of seizures despite treatment and other complications such as maternal ICU admission or neonatal ICU admission. Participants have already received magnesium sulphate as part of their medical care. Researchers will examine data like age, medical history, blood pressure, lab tests, and treatment details from records. The main outcome measured is whether seizures occurred within 24 hours before or after delivery. The study also monitors side effects and complications related to the treatment. Confidentiality and ethical approval are ensured throughout the data review process.

Different Regimens of Magnesium Sulphate in Patients With Severe Preeclampsia